https://www.selleckchem.com/pr....oducts/dibutyryl-cam
001) and less comorbid than logEuroSCORE ≥20% patients, with a higher rate of transfemoral TAVI (35.6% vs 26.1%; p less then 0.001) and predilation (70.0% vs 63.3%; p=0.004). Patients with a logEuroSCORE less then 20% experienced more vascular complications (3.4% vs 1.5%; p=0.01. One-year survival was 88.3% in the logEuroSCORE less then 20% and 81.8% in the logEuroSCORE ≥20% group (p=0.005), with the calculated mortality risk falling within 2% of the logEuroSCORE in just 12.9% of patients. In the logEuroSCORE less t
Like
Comment
Share
